{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:03:51Z","timestamp":1790712231615,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010969","name":"Alzheimer Nederland","doi-asserted-by":"publisher","award":["WE.09-2018-07"],"award-info":[{"award-number":["WE.09-2018-07"]}],"id":[{"id":"10.13039\/501100010969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010969","name":"Alzheimer Nederland","doi-asserted-by":"publisher","award":["WE.09-2018-07"],"award-info":[{"award-number":["WE.09-2018-07"]}],"id":[{"id":"10.13039\/501100010969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010969","name":"Alzheimer Nederland","doi-asserted-by":"publisher","award":["WE.09-2018-07"],"award-info":[{"award-number":["WE.09-2018-07"]}],"id":[{"id":"10.13039\/501100010969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010969","name":"Alzheimer Nederland","doi-asserted-by":"publisher","award":["WE.09-2018-07"],"award-info":[{"award-number":["WE.09-2018-07"]}],"id":[{"id":"10.13039\/501100010969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010969","name":"Alzheimer Nederland","doi-asserted-by":"publisher","award":["WE.09-2018-07"],"award-info":[{"award-number":["WE.09-2018-07"]}],"id":[{"id":"10.13039\/501100010969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["#733050512"],"award-info":[{"award-number":["#733050512"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ABOARD; receiving funding from ZonMw and Health~Holland","award":["#73305095007; #LSHM20106"],"award-info":[{"award-number":["#73305095007; #LSHM20106"]}]},{"name":"ABOARD; receiving funding from ZonMw and Health~Holland","award":["#73305095007; #LSHM20106"],"award-info":[{"award-number":["#73305095007; #LSHM20106"]}]},{"name":"NWO (Dutch Research Council) grant for Computing Time on Cartesius supercomputer","award":["project numbers 15318 and 17232"],"award-info":[{"award-number":["project numbers 15318 and 17232"]}]},{"name":"NWO (Dutch Research Council) grant for Computing Time on Cartesius supercomputer","award":["project numbers 15318 and 17232"],"award-info":[{"award-number":["project numbers 15318 and 17232"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Many families with clinical early-onset Alzheimer\u2019s disease (EOAD) remain genetically unexplained. A combination of genetic factors is not standardly investigated. In addition to monogenic causes, we evaluated the possible polygenic architecture in a large series of families, to assess if genetic testing of familial EOAD could be expanded.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Thirty-six pedigrees (77 patients) were ascertained from a larger cohort of patients, with relationships determined by genetic data (exome sequencing data and\/or SNP arrays). All families included at least one AD patient with symptom onset &lt;70 years. We evaluated segregating rare variants in known dementia-related genes, and other genes or variants if shared by multiple families.<jats:italic>APOE<\/jats:italic>was genotyped and duplications in<jats:italic>APP<\/jats:italic>were assessed by targeted test or using SNP array data. We computed polygenic risk scores (PRS) compared with a reference population-based dataset, by imputing SNP arrays or exome sequencing data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In eight families, we identified a pathogenic variant, including the genes<jats:italic>APP<\/jats:italic>,<jats:italic>PSEN1<\/jats:italic>,<jats:italic>SORL1<\/jats:italic>, and an unexpected<jats:italic>GRN<\/jats:italic>frameshift variant.<jats:italic>APOE<\/jats:italic>-\u03b54 homozygosity was present in eighteen families, showing full segregation with disease in seven families. Eight families harbored a variant of uncertain significance (VUS), of which six included<jats:italic>APOE<\/jats:italic>-\u03b54 homozygous carriers. PRS was not higher in the families combined compared with the population mean (beta 0.05,<jats:italic>P<\/jats:italic>= 0.21), with a maximum increase of 0.61 (OR = 1.84) in the<jats:italic>GRN<\/jats:italic>family. Subgroup analyses indicated lower PRS in six<jats:italic>APP<\/jats:italic>\/<jats:italic>PSEN1<\/jats:italic>families compared with the rest (beta \u22120.22 vs. 0.10;<jats:italic>P<\/jats:italic>= 0.009) and lower<jats:italic>APOE<\/jats:italic>burden in all eight families with monogenic cause (beta 0.29 vs. 1.15,<jats:italic>P<\/jats:italic>= 0.010). Nine families remained without a genetic cause or risk factor identified.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Besides monogenic causes, we suspect\u00a0a polygenic disease architecture in multiple families based on<jats:italic>APOE<\/jats:italic>and rare VUS. The risk conveyed by PRS is modest across the studied families. Families without any identified risk factor render suitable candidates for further in-depth genetic evaluation.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13195-022-01018-3","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T08:38:46Z","timestamp":1654072726000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Mapping the genetic landscape of early-onset Alzheimer\u2019s disease in a cohort of 36 families"],"prefix":"10.1186","volume":"14","author":[{"given":"Merel O.","family":"Mol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven J.","family":"van der Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Hulsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolande A. L.","family":"Pijnenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Scheltens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Netherlands Brain Bank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harro","family":"Seelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"van Swieten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Donker","family":"Kaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henne","family":"Holstege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen G. J.","family":"van Rooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"issue":"3","key":"1018_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jalz.2019.01.010","volume":"15","author":"Alzheimer's A","year":"2019","unstructured":"Alzheimer's A. 2019 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2019;15(3):321\u201387.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"1018_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"M Gm","year":"2011","unstructured":"Gm M, Ds K, Chertkow H, Bt H, Cr JJ, Kawas C, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute On Aging-Alzheimer\u2019s Association Workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):263\u20139.","journal-title":"Alzheimers Dement"},{"key":"1018_CR3","doi-asserted-by":"publisher","unstructured":"Bellenguez C, K\u00fc\u00e7\u00fckali F, Jansen IE, et al. New insights into the genetic etiology of Alzheimer's disease and related dementias. Nat Genet. 2022;54(4):412-36. https:\/\/doi.org\/10.1038\/s41588-022-01024-z.","DOI":"10.1038\/s41588-022-01024-z"},{"issue":"3","key":"1018_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41593-020-0599-5","volume":"23","author":"R Sims","year":"2020","unstructured":"Sims R, Hill M, Williams J. The multiplex model of the genetics of Alzheimer\u2019s disease. Nat Neurosci. 2020;23(3):311\u201322.","journal-title":"Nat Neurosci"},{"issue":"2","key":"1018_CR5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","volume":"63","author":"M Gatz","year":"2006","unstructured":"Gatz M, Ca R, Fratiglioni L, Johansson B, Ja M, Berg S, et al. Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry. 2006;63(2):168\u201374.","journal-title":"Arch Gen Psychiatry"},{"issue":"5123","key":"1018_CR6","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"E Corder","year":"1993","unstructured":"Corder E, Am S, Wj S, De S, Pc G, Small G, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science. 1993;261(5123):921\u20133.","journal-title":"Science."},{"issue":"8","key":"1018_CR7","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S1474-4422(16)00127-7","volume":"15","author":"E Cuyvers","year":"2016","unstructured":"Cuyvers E, Sleegers K. Genetic variations underlying Alzheimer\u2019s disease: evidence from genome-wide association studies and beyond. Lancet Neurol. 2016;15(8):857\u201368.","journal-title":"Lancet Neurol"},{"issue":"12","key":"1018_CR8","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet. 2013;45(12):1452\u20138.","journal-title":"Nat Genet"},{"issue":"9","key":"1018_CR9","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/mp.2012.15","volume":"17","author":"C Pottier","year":"2012","unstructured":"Pottier C, Hannequin D, Coutant S, Rovelet-Lecrux A, Wallon D, Rousseau S, et al. High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease. Mol Psychiatry. 2012;17(9):875\u20139.","journal-title":"Mol Psychiatry"},{"issue":"8","key":"1018_CR10","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1001\/jamaneurol.2015.0979","volume":"72","author":"O Korvatska","year":"2015","unstructured":"Korvatska O, Jb L, Jayadev S, Mcmillan P, Kurtz I, Guo X, et al. R47h variant of Trem2 associated with Alzheimer disease in a large late-onset family: clinical, genetic, and neuropathological study. JAMA Neurol. 2015;72(8):920\u20137.","journal-title":"JAMA Neurol"},{"issue":"220","key":"1018_CR11","first-page":"E1","volume":"59","author":"C Bellenguez","year":"2017","unstructured":"Bellenguez C, Charbonnier C, Grenier-Boley B, Quenez O, Le Guennec K, Nicolas G, et al. Contribution to Alzheimer\u2019s disease risk of rare variants in Trem2, Sorl1, And Abca7 in 1779 cases and 1273 controls. Neurobiol Aging. 2017;59(220):E1\u20139.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"1018_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00401-019-01994-1","volume":"138","author":"A De Roeck","year":"2019","unstructured":"De Roeck A, Van Broeckhoven C, Sleegers K. The role of Abca7 in Alzheimer\u2019s disease: evidence from genomics, transcriptomics and methylomics. Acta Neuropathol. 2019;138(2):201\u201320.","journal-title":"Acta Neuropathol"},{"issue":"7484","key":"1018_CR13","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nature12825","volume":"505","author":"C Cruchaga","year":"2014","unstructured":"Cruchaga C, Cm K, Sc J, Ba B, Cai Y, Guerreiro R, et al. Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer\u2019s disease. Nature. 2014;505(7484):550\u20134.","journal-title":"Nature."},{"issue":"1","key":"1018_CR14","doi-asserted-by":"publisher","first-page":"E41","DOI":"10.1212\/NXG.0000000000000041","volume":"2","author":"MA Kohli","year":"2016","unstructured":"Kohli MA, Cukier HN, Hamilton-Nelson KL, Rolati S, Kunkle BW, Whitehead PL, et al. Segregation of a rare TTC3 variant in an extended family with late-onset Alzheimer disease. Neurol Genet. 2016;2(1):E41.","journal-title":"Neurol Genet"},{"key":"1018_CR15","doi-asserted-by":"publisher","unstructured":"Cukier HN, Kunkle BK, Hamilton KL, et al. Exome Sequencing of Extended Families with Alzheimer's Disease Identifies Novel Genes Implicated in Cell Immunity and Neuronal Function. J Alzheimers Dis Parkinsonism. 2017;7(4):355.https:\/\/doi.org\/10.4172\/2161-0460.1000355.","DOI":"10.4172\/2161-0460.1000355"},{"issue":"2","key":"1018_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jalz.2017.08.013","volume":"14","author":"C Cruchaga","year":"2018","unstructured":"Cruchaga C, Del-Aguila JL, Saef B, Black K, Mv F, Budde J, et al. Polygenic risk score of sporadic late-onset Alzheimer\u2019s disease reveals a shared architecture with the familial and early-onset forms. Alzheimers Dement. 2018;14(2):205\u201314.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1018_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3233\/JAD-132306","volume":"41","author":"WM van der Flier","year":"2014","unstructured":"van der Flier WM, Pijnenburg YA, Prins N, Lemstra AW, Bouwman FH, Teunissen CE, et al. Optimizing patient care and research: the Amsterdam dementia cohort. J Alzheimers Dis. 2014;41(1):313\u201327.","journal-title":"J Alzheimers Dis"},{"key":"1018_CR18","doi-asserted-by":"crossref","unstructured":"Holstege H, Hulsman M, Charbonnier C, Grenier-Boley B, Quenez O, Grozeva D, et al. Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as novel risk factors for Alzheimer\u2019s Disease. medRxiv. 2022:2020.07.22.20159251. https:\/\/doi.org\/10.1101\/2020.07.22.20159251.","DOI":"10.1101\/2020.07.22.20159251"},{"issue":"14","key":"1018_CR19","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows\u2013Wheeler transform. Bioinformatics. 2009;25(14):1754\u201360.","journal-title":"Bioinformatics."},{"issue":"9","key":"1018_CR20","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A Mckenna","year":"2010","unstructured":"Mckenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297\u2013303.","journal-title":"Genome Res"},{"issue":"16","key":"1018_CR21","doi-asserted-by":"publisher","first-page":"E164-E","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H. Annovar: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):E164-E.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"1018_CR22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K, Thomas L, Ma F, Bender D, et al. Plink: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559\u201375.","journal-title":"Am J Hum Genet"},{"issue":"22","key":"1018_CR23","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1093\/bioinformatics\/btq559","volume":"26","author":"A Manichaikul","year":"2010","unstructured":"Manichaikul A, Mychaleckyj JC, Rich SS, Daly K, Sale M, Wm C. Robust relationship inference in genome-wide association studies. Bioinformatics. 2010;26(22):2867\u201373.","journal-title":"Bioinformatics."},{"issue":"11","key":"1018_CR24","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1101\/gr.6861907","volume":"17","author":"K Wang","year":"2007","unstructured":"Wang K, Li M, Hadley D, Liu R, Glessner J, Sf G, et al. Penncnv: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res. 2007;17(11):1665\u201374.","journal-title":"Genome Res"},{"issue":"7809","key":"1018_CR25","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434\u201343.","journal-title":"Nature."},{"issue":"10","key":"1018_CR26","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/gim.2017.37","volume":"19","author":"K Nykamp","year":"2017","unstructured":"Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Yy H, et al. Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria. Genet Med. 2017;19(10):1105\u201317.","journal-title":"Genet Med"},{"issue":"21","key":"1018_CR27","doi-asserted-by":"publisher","first-page":"E31","DOI":"10.1158\/0008-5472.CAN-17-0337","volume":"77","author":"JT Robinson","year":"2017","unstructured":"Robinson JT, Thorvaldsd\u00f3ttir H, Wenger AM, Zehir A, Mesirov JP. Variant review with the Integrative Genomics Viewer. Cancer Res. 2017;77(21):E31\u2013E4.","journal-title":"Cancer Res"},{"issue":"1","key":"1018_CR28","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1038\/s41467-021-22491-8","volume":"12","author":"I De Rojas","year":"2021","unstructured":"De Rojas I, Moreno-Grau S, Tesi N, Grenier-Boley B, Andrade V, Jansen IE, et al. Common variants in Alzheimer\u2019s disease and risk stratification by polygenic risk scores. Nat Commun. 2021;12(1):3417.","journal-title":"Nat Commun"},{"issue":"3","key":"1018_CR29","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates a\u03b2, tau, immunity and lipid processing. Nat Genet. 2019;51(3):414\u201330.","journal-title":"Nat Genet"},{"issue":"9","key":"1018_CR30","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/ng.3916","volume":"49","author":"R Sims","year":"2017","unstructured":"Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, et al. Rare coding variants in Plcg2, Abi3, And Trem2 implicate microglial-mediated innate immunity in Alzheimer\u2019s disease. Nat Genet. 2017;49(9):1373\u201384.","journal-title":"Nat Genet"},{"issue":"1","key":"1018_CR31","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/mp.2015.23","volume":"21","author":"G Jun","year":"2016","unstructured":"Jun G, Ibrahim-Verbaas CA, Vronskaya M, Lambert JC, Chung J, Naj AC, et al. A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry. 2016;21(1):108\u201317.","journal-title":"Mol Psychiatry"},{"issue":"8","key":"1018_CR32","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/ejhg.2017.87","volume":"25","author":"H Holstege","year":"2017","unstructured":"Holstege H, van der Lee SJ, Hulsman M, Wong TH, van Rooij JG, Weiss M, et al. Characterization of pathogenic SORL1 genetic variants for association with Alzheimer\u2019s disease: a clinical interpretation strategy. Eur J Hum Genet. 2017;25(8):973\u201381.","journal-title":"Eur J Hum Genet"},{"issue":"7105","key":"1018_CR33","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nature05016","volume":"442","author":"M Baker","year":"2006","unstructured":"Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442(7105):916\u20139.","journal-title":"Nature."},{"issue":"20","key":"1018_CR34","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1093\/hmg\/ddl241","volume":"15","author":"J Gass","year":"2006","unstructured":"Gass J, Cannon A, Ir M, Boeve B, Baker M, Adamson J, et al. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet. 2006;15(20):2988\u20133001.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"1018_CR35","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/WAD.0b013e3181fbc22c","volume":"25","author":"L Skoglund","year":"2011","unstructured":"Skoglund L, Matsui T, Freeman S, Wallin A, Es B, Mp F, et al. Novel progranulin mutation detected in 2 patients with FTLD. Alzheimer Dis Assoc Disord. 2011;25(2):173\u20138.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"15","key":"1018_CR36","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1212\/WNL.0b013e31826e25df","volume":"79","author":"E Rubino","year":"2012","unstructured":"Rubino E, Rainero I, Chi\u00f2 A, Rogaeva E, Galimberti D, Fenoglio P, et al. Sqstm1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Neurology. 2012;79(15):1556\u201362.","journal-title":"Neurology."},{"issue":"2","key":"1018_CR37","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","volume":"19","author":"C Blauwendraat","year":"2020","unstructured":"Blauwendraat C, Nalls MA, Singleton AB. The genetic architecture of parkinson\u2019s disease. Lancet Neurol. 2020;19(2):170\u20138.","journal-title":"Lancet Neurol"},{"issue":"6","key":"1018_CR38","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.tig.2018.03.001","volume":"34","author":"HP Nguyen","year":"2018","unstructured":"Nguyen HP, Van Broeckhoven C, van der Zee J. ALS genes in the genomic era and their implications for FTD. Trends Genet. 2018;34(6):404\u201323.","journal-title":"Trends Genet"},{"issue":"Pt 11","key":"1018_CR39","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1093\/brain\/awl267","volume":"129","author":"JS Snowden","year":"2006","unstructured":"Snowden JS, Pickering-Brown SM, Mackenzie IR, Richardson AM, Varma A, Neary D, et al. Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia. Brain. 2006;129(Pt 11):3091\u2013102.","journal-title":"Brain."},{"issue":"Pt 11","key":"1018_CR40","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1093\/brain\/awl271","volume":"129","author":"IR Mackenzie","year":"2006","unstructured":"Mackenzie IR, Baker M, Pickering-Brown S, Hsiung GY, Lindholm C, Dwosh E, et al. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain. 2006;129(Pt 11):3081\u201390.","journal-title":"Brain."},{"issue":"5","key":"1018_CR41","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/jnen\/nly018","volume":"77","author":"T Gefen","year":"2018","unstructured":"Gefen T, Ahmadian SS, Mao Q, Kim G, Seckin M, Bonakdarpour B, et al. Combined pathologies in Ftld-Tdp types A and C. J Neuropathol Exp Neurol. 2018;77(5):405\u201312.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"1018_CR42","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/bpa.12480","volume":"28","author":"V Redaelli","year":"2018","unstructured":"Redaelli V, Rossi G, Maderna E, Gg K, Piccoli E, Caroppo P, et al. Alzheimer neuropathology without frontotemporal lobar degeneration hallmarks (TAR DNA-binding protein 43 inclusions) in missense progranulin mutation Cys139arg. Brain Pathol. 2018;28(1):72\u20136.","journal-title":"Brain Pathol"},{"issue":"6","key":"1018_CR43","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1007\/s12035-015-9358-0","volume":"53","author":"H Jing","year":"2016","unstructured":"Jing H, Tan MS, Yu JT, Tan L. The role of Pgrn in Alzheimer\u2019s disease. Mol Neurobiol. 2016;53(6):4189\u201396.","journal-title":"Mol Neurobiol"},{"issue":"5","key":"1018_CR44","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s40291-018-0347-7","volume":"22","author":"JS Goldman","year":"2018","unstructured":"Goldman JS, Van Deerlin VM. Alzheimer\u2019s disease and frontotemporal dementia: the current state of genetics and genetic testing since the advent of next-generation sequencing. Mol Diagn Ther. 2018;22(5):505\u201313.","journal-title":"Mol Diagn Ther"},{"issue":"1","key":"1018_CR45","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.pneurobio.2011.11.005","volume":"96","author":"A Salminen","year":"2012","unstructured":"Salminen A, Kaarniranta K, Haapasalo A, Hiltunen M, Soininen H, Alafuzoff I. Emerging role Of P62\/sequestosome-1 in the pathogenesis of Alzheimer\u2019s disease. Prog Neurobiol. 2012;96(1):87\u201395.","journal-title":"Prog Neurobiol"},{"issue":"1","key":"1018_CR46","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1471-4159.2008.05340.x","volume":"106","author":"J Ramesh Babu","year":"2008","unstructured":"Ramesh Babu J, Lamar Seibenhener M, Peng J, Strom AL, Kemppainen R, Cox N, et al. Genetic inactivation of P62 leads to accumulation of hyperphosphorylated tau and neurodegeneration. J Neurochem. 2008;106(1):107\u201320.","journal-title":"J Neurochem"},{"issue":"4","key":"1018_CR47","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.freeradbiomed.2008.11.003","volume":"46","author":"Y Du","year":"2009","unstructured":"Du Y, Wooten MC, Gearing M, Wooten MW. Age-associated oxidative damage to the P62 promoter: implications for Alzheimer disease. Free Radic Biol Med. 2009;46(4):492\u2013501.","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"1018_CR48","doi-asserted-by":"publisher","first-page":"2005 E15","DOI":"10.1016\/j.neurobiolaging.2015.02.014","volume":"36","author":"E Cuyvers","year":"2015","unstructured":"Cuyvers E, Van Der Zee J, Bettens K, Engelborghs S, Vandenbulcke M, Robberecht C, et al. Genetic variability in Sqstm1 and risk of early-onset Alzheimer dementia: a European Early-Onset Dementia Consortium Study. Neurobiol Aging. 2015;36(5):2005 E15\u201322.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"1018_CR49","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3233\/JAD-201231","volume":"79","author":"T Carandini","year":"2021","unstructured":"Carandini T, Sacchi L, Ghezzi L, Pietroboni AM, Fenoglio C, Arighi A, et al. Detection of the Sqstm1 mutation in a patient with early-onset hippocampal amnestic syndrome. J Alzheimers Dis. 2021;79(2):477\u201381.","journal-title":"J Alzheimers Dis"},{"key":"1018_CR50","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fnagi.2018.00026","volume":"10","author":"L Sun","year":"2018","unstructured":"Sun L, Rong Z, Li W, Zheng H, Xiao S, Li X. Identification of a novel hemizygous Sqstm1 nonsense mutation in atypical behavioral variant frontotemporal dementia. Front Aging Neurosci. 2018;10:26.","journal-title":"Front Aging Neurosci"},{"key":"1018_CR51","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.2147\/NDT.S165445","volume":"14","author":"E Bagyinszky","year":"2018","unstructured":"Bagyinszky E, Giau VV, Youn YC, An SSA, Kim S. Characterization of mutations in Prnp (prion) gene and their possible roles in neurodegenerative diseases. Neuropsychiatr Dis Treat. 2018;14:2067\u201385.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"2","key":"1018_CR52","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3233\/JAD-150863","volume":"50","author":"E Oldoni","year":"2016","unstructured":"Oldoni E, Fumagalli GG, Serpente M, Fenoglio C, Scarioni M, Arighi A, et al. Prnp P39l variant is a rare cause of frontotemporal dementia in Italian population. J Alzheimers Dis. 2016;50(2):353\u20137.","journal-title":"J Alzheimers Dis"},{"key":"1018_CR53","doi-asserted-by":"publisher","first-page":"38435","DOI":"10.1038\/srep38435","volume":"6","author":"W Zhang","year":"2016","unstructured":"Zhang W, Jiao B, Xiao T, Pan C, Liu X, Zhou L, et al. Mutational analysis of Prnp in Alzheimer\u2019s disease and frontotemporal dementia in China. Sci Rep. 2016;6:38435.","journal-title":"Sci Rep"},{"issue":"9","key":"1018_CR54","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/mp.2011.52","volume":"16","author":"E Genin","year":"2011","unstructured":"Genin E, Hannequin D, Wallon D, Sleegers K, Hiltunen M, Combarros O, et al. Apoe and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry. 2011;16(9):903\u20137.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"1018_CR55","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/JAD-160091","volume":"56","author":"E Louwersheimer","year":"2017","unstructured":"Louwersheimer E, Cohn-Hokke PE, Pijnenburg YAL, Weiss MM, Sistermans EA, Rozemuller AJ, et al. Rare genetic variant in Sorl1 may increase penetrance of Alzheimer\u2019s disease in a family with several generations of Apoe-\u01904 homozygosity. J Alzheimers Dis. 2017;56(1):63\u201374.","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"1018_CR56","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.bbalip.2010.04.005","volume":"1801","author":"L Jones","year":"2010","unstructured":"Jones L, Harold D, Williams J. Genetic evidence for the involvement of lipid metabolism in Alzheimer\u2019s disease. Biochim Biophys Acta. 2010;1801(8):754\u201361.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1018_CR57","first-page":"344","volume":"11","author":"Y Liu","year":"2021","unstructured":"Liu Y, Thalamuthu A, Mather KA, Crawford J, Ulanova M, Wong MWK, et al. Plasma lipidome is dysregulated in Alzheimer\u2019s disease and is associated with disease risk genes. Transl. Psychiatry. 2021;11(1):344.","journal-title":"Psychiatry."},{"key":"1018_CR58","first-page":"101.E1","volume":"99","author":"B Fulton-Howard","year":"2021","unstructured":"Fulton-Howard B, Goate AM, Adelson RP, Koppel J, Gordon ML, Barzilai N, et al. Greater effect of polygenic risk score for Alzheimer\u2019s disease among younger cases who are apolipoprotein E-\u03954 carriers. Neurobiology Of. Aging. 2021;99:101.E1\u20139.","journal-title":"Aging."},{"issue":"6","key":"1018_CR59","first-page":"597","volume":"13","author":"JS Goldman","year":"2011","unstructured":"Goldman JS, Hahn SE, Catania JW, Larusse-Eckert S, Butson MB, Rumbaugh M, et al. Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College Of Medical Genetics And The National Society Of Genetic Counselors. Genetics In Medicine : Official Journal Of The American College Of Medical. Genetics. 2011;13(6):597\u2013605.","journal-title":"Genetics."},{"key":"1018_CR60","unstructured":"Food and Drug Administration. Evaluation of automatic class III designation for the 23 and Me Personal Genome Service (PGS) genetic health risk test for hereditary thrombophilia, alpha\u20101 antitrypsin deficiency, Alzheimer's disease, Parkinson's disease, Gaucher disease type 1, factor XI deficiency, celiac disease, G6PD deficiency, hereditary hemochromatosis and early\u2010onset primary dystonia. Decision summary. 2017. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/reviews\/den160026.pdf."},{"issue":"3","key":"1018_CR61","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1056\/NEJMoa0809578","volume":"361","author":"RC Green","year":"2009","unstructured":"Green RC, Roberts JS, Cupples LA, Relkin NR, Whitehouse PJ, Brown T, et al. Disclosure of Apoe genotype for risk of Alzheimer\u2019s disease. N Engl J Med. 2009;361(3):245\u201354.","journal-title":"N Engl J Med"},{"issue":"1","key":"1018_CR62","first-page":"E12002-E","volume":"6","author":"KD Christensen","year":"2020","unstructured":"Christensen KD, Karlawish J, Roberts JS, Uhlmann WR, Harkins K, Wood EM, et al. Disclosing genetic risk for Alzheimer\u2019s dementia to individuals with mild cognitive impairment. Alzheimers Dementia (New York, NY). 2020;6(1):E12002-E.","journal-title":"Alzheimers Dementia (New York, NY)"},{"issue":"12","key":"1018_CR63","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/medethics-2018-104772","volume":"44","author":"EM Bunnik","year":"2018","unstructured":"Bunnik EM, Richard E, Milne R, Schermer MHN. On the personal utility of Alzheimer\u2019s disease-related biomarker testing in the research context. J Med Ethics. 2018;44(12):830\u20134.","journal-title":"J Med Ethics"},{"issue":"5","key":"1018_CR64","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S1474-4422(18)30053-X","volume":"17","author":"SJ van der Lee","year":"2018","unstructured":"van der Lee SJ, Wolters FJ, Ikram MK, Hofman A, Ikram MA, Amin N, et al. The effect of Apoe and other common genetic variants on the onset of Alzheimer\u2019s disease and dementia: a community-based cohort study. Lancet Neurol. 2018;17(5):434\u201344.","journal-title":"Lancet Neurol"},{"issue":"1","key":"1018_CR65","doi-asserted-by":"crossref","first-page":"E12211","DOI":"10.1002\/trc2.12211","volume":"7","author":"SP Dickson","year":"2021","unstructured":"Dickson SP, Hendrix SB, Brown BL, Ridge PG, Nicodemus-Johnson J, Hardy ML, et al. Genorisk: a polygenic risk score for Alzheimer\u2019s disease. Alzheimers Dement (N Y). 2021;7(1):E12211.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"R2","key":"1018_CR66","doi-asserted-by":"publisher","first-page":"R133","DOI":"10.1093\/hmg\/ddz187","volume":"28","author":"SA Lambert","year":"2019","unstructured":"Lambert SA, Abraham G, Inouye M. Towards clinical utility of polygenic risk scores. Hum Mol Genet. 2019;28(R2):R133\u2013R42.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1018_CR67","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1038\/s41467-020-17374-3","volume":"11","author":"AC Fahed","year":"2020","unstructured":"Fahed AC, Wang M, Homburger JR, Patel AP, Bick AG, Neben CL, et al. Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions. Nat Commun. 2020;11(1):3635.","journal-title":"Nat Commun"},{"issue":"9","key":"1018_CR68","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/hq0901.094500","volume":"21","author":"K Taira","year":"2001","unstructured":"Taira K, Bujo H, Hirayama S, Yamazaki H, Kanaki T, Takahashi K, et al. Lr11, A mosaic Ldl receptor family member, mediates the uptake of Apoe-rich lipoproteins in vitro. Arterioscler Thromb Vasc Biol. 2001;21(9):1501\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1018_CR69","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cca.2018.11.024","volume":"489","author":"K Yano","year":"2019","unstructured":"Yano K, Hirayama S, Misawa N, Furuta A, Ueno T, Motoi Y, et al. Soluble Lr11 competes with amyloid \u0392 in binding to cerebrospinal fluid-high-density lipoprotein. Clin Chim Acta. 2019;489:29\u201334.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"1018_CR70","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13195-019-0563-3","volume":"11","author":"YT Chang","year":"2019","unstructured":"Chang YT, Hsu SW, Huang SH, Huang CW, Chang WN, Lien CY, et al. Abca7 polymorphisms correlate with memory impairment and default mode network in patients with Apoe\u03b54-associated Alzheimer\u2019s disease. Alzheimers Res Ther. 2019;11(1):103.","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"1018_CR71","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3233\/JAD-130482","volume":"36","author":"CD Engelman","year":"2013","unstructured":"Engelman CD, Koscik RL, Jonaitis EM, Okonkwo OC, Hermann BP, La Rue A, et al. Interaction between two cholesterol metabolism genes influences memory: findings from the Wisconsin Registry For Alzheimer\u2019s Prevention. J Alzheimers Dis. 2013;36(4):749\u201357.","journal-title":"J Alzheimers Dis"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-01018-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-022-01018-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-01018-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T14:03:22Z","timestamp":1700661802000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-022-01018-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1018"],"URL":"https:\/\/doi.org\/10.1186\/s13195-022-01018-3","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,1]]},"assertion":[{"value":"4 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Medical Ethical Committee of the Erasmus Medical Center Rotterdam. Brain autopsy was conducted by the Netherlands Brain Bank (NBB) at the designated premises of the VU Medical Center in Amsterdam (the Netherlands). Ethical approval for the NBB procedures and forms was given by the Medical Ethics Committee of the VU Medical Center. Written informed consent for the use of tissues, clinical, and neuropathological data was obtained from all participants or their legal representatives, according to the Code of conduct for Brain Banking and Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}